G. Averion - NIH, Neuromuscular & Neurogenet Disorders Childhood Se

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

491P PIEZO2 Loss of Function Syndrome: a Highly Specific and Recognizable Phenotype

D. Bharucha-Goebel, M. Lee,D. Saade, S. Donkervoort,P. Yun,P. Mohassel,S. Neuhaus, T. Ogata,G. Averion, C. Mendoza,K. Alter, J. Matsubara, C. Stanley, C. Zampieri,T. Lehky, A. Nickolls, A. Chesler, A. Foley, C. Bonnemann

Neuromuscular Disorders（2024）

引用0浏览0引用

P444 Ophthalmologic Findings Following Intrathecal AAV9 Mediated Gene Transfer for Giant Axonal Neuropathy

D. Bharucha-Goebel,D. Saade, J. Todd,L. Huryn,G. Norato,T. DeLong,G. Averion,S. Donkervoort,A. Foley,N. Acquaye,C. Mendoza,S. Gray,W. Zein,C. Bonnemann

NEUROMUSCULAR DISORDERS (2023): S189-S189

引用0浏览0引用

P445 Electrophysiologic and Histologic Findings Following Intrathecal AAV9 Mediated Gene Transfer for Giant Axonal Neuropathy

D. Bharucha-Goebel,D. Saade, J. Todd,T. Lehky,G. Norato, D. Armao, T. Bouldin,G. Averion,Y. Hu,P. Mohassel,S. Donkervoort,A. Corse,A. Foley,T. DeLong,N. Acquaye,L. Hinkley,C. Mendoza,A. Hoke,S. Gray,C. Bonnemann

NEUROMUSCULAR DISORDERS (2023): S189-S190

引用0浏览0引用

Serum Neurofilament Light Chain Analysis In Giant Axonal Neuropathy

D. Bharucha-Goebel,D. Saade,E. Paredes,Y. Hu, A. Saxena,P. Mccoy,G. Averion,M. Jain,G. Norato,K. Cheung,M. Waite,R. Foley,T. Lehky, S. Gray,C. Bonnemann

NEUROMUSCULAR DISORDERS（2021）

引用0浏览0引用

OUTCOME MEASURES EP.326 Serum neurofilament light chain analysis in giant axonal neuropathy

D. Bharucha-Goebel,D. Saade,E. Paredes,Y. Hu,A. Saxena,P. McCoy,G. Averion,M. Jain,G. Norato,K. Cheung,M. Waite,R. Foley,T. Lehky,S. Gray,C. Bönnemann

Neuromuscular Disorders (2021)

引用0浏览0引用

OUTCOME MEASURES

D. Bharucha-Goebel,D. Saade,E. Paredes,Y. Hu, A. Saxena,P. McCoy,G. Averion,M. Jain,G. Norato,K. Cheung,M. Waite,R. Foley,T. Lehky, S. Gray,C. Bönnemann

Neuromuscular Disorders（2021）

引用0浏览0引用

CONGENITAL MUSCULAR DYSTROPHY: LAMA2: P.329CALLISTO: A phase I open-label, sequential group, cohort study of pharmacokinetics and safety of omigapil in LAMA2 and COL6-related dystrophy patients

A. Foley,M. Leach,G. Averion,Y. Hu,P. Yun,S. Neuhaus,D. Saade,C. Arévalo,M. Fink,J. DeCoster,C. Mendoza,O. Mayer,R. Hausmann,D. Petraki,K. Cheung,C. Bönnemann

Neuromuscular Disorders (2019): S163-S130

引用0浏览0引用

CONGENITAL MUSCULAR DYSTROPHY: LAMA2

A. Foley,M. Leach,G. Averion, Y. Hu,P. Yun,S. Neuhaus,D. Saade,C. Arévalo,M. Fink,J. DeCoster,C. Mendoza,O. Mayer,R. Hausmann,D. Petraki,K. Cheung,C. Bönnemann

NEUROMUSCULAR DISORDERS（2019）

引用0浏览0引用

CALLISTO: a phase I open-label, sequential group, cohort study of pharmacokinetics and safety of omigapil in LAMA2 and COL6-related dystrophy patients

A. R. Foley,M. Leach,G. Averion,Y. Hu,P. Yun,S. Neuhaus,D. Saade,C. Arevalo,M. Fink,J. DeCoster,C. Mendoza,O. Mayer,R. Hausmann,D. Petraki,K. Cheung,C. Bonnemann

Neuromuscular Disordersno. SUPnan (2018): S129-S130

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn